| Product Code: ETC7548403 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India multiple sclerosis therapies market import shipments witnessed robust growth with a remarkable CAGR from 2020-2024. Notably, the growth momentum accelerated between 2023 and 2024, indicating a significant uptrend in market expansion. The market demonstrated a strong upward trajectory, showcasing a dynamic and thriving landscape during this period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Multiple Sclerosis Therapies Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Multiple Sclerosis Therapies Market Revenues & Volume, 2021 & 2031F |
3.3 India Multiple Sclerosis Therapies Market - Industry Life Cycle |
3.4 India Multiple Sclerosis Therapies Market - Porter's Five Forces |
3.5 India Multiple Sclerosis Therapies Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Multiple Sclerosis Therapies Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Multiple Sclerosis Therapies Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 India Multiple Sclerosis Therapies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multiple sclerosis in India |
4.2.2 Growing awareness about the disease and available treatment options |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in India |
4.3 Market Restraints |
4.3.1 High cost associated with multiple sclerosis therapies |
4.3.2 Limited access to advanced treatments in rural areas of India |
4.3.3 Stringent regulations and approval processes for new therapies |
5 India Multiple Sclerosis Therapies Market Trends |
6 India Multiple Sclerosis Therapies Market, By Types |
6.1 India Multiple Sclerosis Therapies Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Multiple Sclerosis Therapies Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Multiple Sclerosis Therapies Market Revenues & Volume, By Immunosuppressants, 2021- 2031F |
6.1.4 India Multiple Sclerosis Therapies Market Revenues & Volume, By Immunomodulators, 2021- 2031F |
6.2 India Multiple Sclerosis Therapies Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Multiple Sclerosis Therapies Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 India Multiple Sclerosis Therapies Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 India Multiple Sclerosis Therapies Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3 India Multiple Sclerosis Therapies Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 India Multiple Sclerosis Therapies Market Revenues & Volume, By Hospital, 2021- 2031F |
6.3.3 India Multiple Sclerosis Therapies Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 India Multiple Sclerosis Therapies Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.5 India Multiple Sclerosis Therapies Market Revenues & Volume, By Others, 2021- 2031F |
7 India Multiple Sclerosis Therapies Market Import-Export Trade Statistics |
7.1 India Multiple Sclerosis Therapies Market Export to Major Countries |
7.2 India Multiple Sclerosis Therapies Market Imports from Major Countries |
8 India Multiple Sclerosis Therapies Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed therapies |
8.2 Number of clinical trials for new multiple sclerosis treatments conducted in India |
8.3 Percentage of neurologists trained in multiple sclerosis management in India |
9 India Multiple Sclerosis Therapies Market - Opportunity Assessment |
9.1 India Multiple Sclerosis Therapies Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Multiple Sclerosis Therapies Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Multiple Sclerosis Therapies Market Opportunity Assessment, By End user, 2021 & 2031F |
10 India Multiple Sclerosis Therapies Market - Competitive Landscape |
10.1 India Multiple Sclerosis Therapies Market Revenue Share, By Companies, 2024 |
10.2 India Multiple Sclerosis Therapies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here